Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,203 | -28,168 | -30,602 | -8,312 | 2,967 |
| Depreciation Amortization | 4,307 | 2,169 | 10,184 | 7,703 | 5,130 |
| Accounts receivable | -50,019 | N/A | 9,512 | 9,512 | 9,512 |
| Accounts payable and accrued liabilities | -575 | -374 | 867 | 240 | 192 |
| Other Working Capital | -10,311 | -8,243 | 19,584 | 19,461 | 21,066 |
| Other Operating Activity | 62,705 | 5,744 | -20,398 | -15,776 | -2,134 |
| Operating Cash Flow | $-53,096 | $-28,872 | $-10,853 | $12,828 | $36,733 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,597 | -818 | -5,053 | -3,548 | -2,815 |
| Purchase Sale Intangibles | N/A | N/A | -750 | -750 | N/A |
| Other Investing Activity | 0 | 0 | -750 | -750 | 0 |
| Investing Cash Flow | $-1,597 | $-818 | $-5,803 | $-4,298 | $-2,815 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 19,970 | N/A | 4,970 | 2,465 | 2,470 |
| Debt Repayment | N/A | N/A | -2,513 | -13 | N/A |
| Common Stock Issued | 75,195 | 2,249 | 68,064 | 41,561 | 47,770 |
| Other Financing Activity | 0 | 0 | 0 | 18,130 | -13 |
| Financing Cash Flow | $95,165 | $2,249 | $70,521 | $62,143 | $50,227 |
| Beginning Cash Position | 143,663 | 143,663 | 89,798 | 89,798 | 89,798 |
| End Cash Position | 184,135 | 116,222 | 143,663 | 160,471 | 173,943 |
| Net Cash Flow | $40,472 | $-27,441 | $53,865 | $70,673 | $84,145 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,096 | -28,872 | -10,853 | 12,828 | 36,733 |
| Capital Expenditure | -1,597 | -818 | -5,053 | -3,548 | -2,815 |
| Free Cash Flow | -54,693 | -29,690 | -15,906 | 9,280 | 33,918 |